4/19
05:19 pm
nlsp
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing [Yahoo! Finance]
4/19
05:00 pm
nlsp
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
Medium
Report
NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing
3/22
04:52 pm
nlsp
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering [Yahoo! Finance]
Medium
Report
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering [Yahoo! Finance]
3/22
04:30 pm
nlsp
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
Medium
Report
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
3/20
01:56 pm
nlsp
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering [Yahoo! Finance]
High
Report
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering [Yahoo! Finance]
3/20
01:40 pm
nlsp
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
High
Report
NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering
3/20
07:34 am
nlsp
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform [Yahoo! Finance]
High
Report
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform [Yahoo! Finance]
3/20
07:30 am
nlsp
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
High
Report
NLS Pharmaceutics Secures Exclusive Global License for Next-Generation Non-Sulfonamide Dual Orexin Agonist Platform
4/19
05:16 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Apr 19
Low
Report
Form 6-K NLS Pharmaceutics Ltd. For: Apr 19
4/15
04:02 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Apr 15
Medium
Report
Form 6-K NLS Pharmaceutics Ltd. For: Apr 15
4/8
04:12 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Apr 08
Medium
Report
Form 6-K NLS Pharmaceutics Ltd. For: Apr 08
4/3
04:02 pm
nlsp
Form D NLS Pharmaceutics Ltd.
Medium
Report
Form D NLS Pharmaceutics Ltd.
3/27
07:38 pm
nlsp
Form SC 13G NLS Pharmaceutics Ltd. Filed by: Lind Global Fund II LP
Medium
Report
Form SC 13G NLS Pharmaceutics Ltd. Filed by: Lind Global Fund II LP
3/22
10:25 am
nlsp
Form 424B5 NLS Pharmaceutics Ltd.
High
Report
Form 424B5 NLS Pharmaceutics Ltd.
3/21
05:15 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Mar 21
Medium
Report
Form 6-K NLS Pharmaceutics Ltd. For: Mar 21
3/20
12:58 pm
nlsp
Form 6-K NLS Pharmaceutics Ltd. For: Mar 20
High
Report
Form 6-K NLS Pharmaceutics Ltd. For: Mar 20
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register